Michael Martin, MD
Orthopaedic Surgery · Birmingham, ALNPI 1588691224
Payments from drug & device makers
Across 57 payments — averaging $65.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Prime Surgical, LLC$759
- Johnson & Johnson$172
- Boston Scientific$75
- Stryker$50
- Pacira Pharmaceuticals Incorporated$50
- plus $368 from 16 others
What the payments were for
- Travel & lodging$1,09429%
- Food & beverage$1,26634%
- Education$1,35036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 17 | $2,236 |
| Prime Surgical, LLC | 4 | $759 |
| Johnson & Johnson(2 entities) | 8 | $172 |
| Boston Scientific | 3 | $75 |
| Stryker | 2 | $50 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Endo Pharmaceuticals Inc. | 3 | $44 |
| Sanofi-aventis U.S. LLC | 3 | $43 |
| Amgen | 2 | $33 |
| Convatec Inc. | 1 | $27 |
| DJO, LLC | 1 | $26 |
| Livanova USA, Inc. | 1 | $23 |
| Avanos Medical | 1 | $22 |
| Heraeus Medical, LLC. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Medtronic | 1 | $18 |
| Vericel Corporation | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Conmed Corporation | 1 | $16 |
| Abiomed | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $13 |
How this compares
$3,711 in reported general payments places this provider in the 55th percentile of 319 orthopaedic surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,682 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 209 | $1,403 |
| Celecoxib | 64 | $1,079 |
| Meloxicam | 95 | $469 |
| Rosuvastatin Calcium | 16 | $414 |
| Methylprednisolone | 37 | $370 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $340 |
| Tramadol Hcl | 102 | $307 |
| Cyclobenzaprine Hcl | 27 | $269 |
| Ibuprofen | 24 | $257 |
| Metoprolol Succinate | 12 | $202 |
| Gabapentin | 15 | $178 |
| Naproxen | 17 | $177 |
| Losartan Potassium | 21 | $142 |
| Atorvastatin Calcium | 12 | $132 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Birmingham
- Jeffrey DugasBirmingham$11.7M
- Benton EmblomBirmingham$3.1M
- Herrick SiegelBirmingham$1.3M
- Kenneth MooreBirmingham$342K
- Jeffrey DavisBirmingham$293K
- Joseph SherrillBirmingham$221K
- Jonathan QuadeBirmingham$219K
- Ginger BryantBirmingham$209K
- Marcus RothermichBirmingham$207K
- Richard SandersBirmingham$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.